Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online April 16, 2008
Diabetes 57:1800-1804, 2008
DOI: 10.2337/db08-0195
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db08-0195v1
57/7/1800    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Basu, R.
Right arrow Articles by Rizza, R. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basu, R.
Right arrow Articles by Rizza, R. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Brief Report

Plasma C5 Glucose–to–2H2O Ratio Does Not Provide an Accurate Assessment of Gluconeogenesis During Hyperinsulinemic-Euglycemic Clamps in Either Nondiabetic or Diabetic Humans

Rita Basu1, Visvanathan Chandramouli2, Betty Dicke1, Bernard R. Landau2,{dagger}, and Robert A. Rizza1

1 Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic College of Medicine, Rochester, Minnesota
2 Division of Clinical and Molecular Endocrinology, Case Western Reserve University School of Medicine, Cleveland, Ohio

Corresponding author: Robert A. Rizza, rizza.robert{at}mayo.edu

OBJECTIVE—Measurement of plasma C2 glucose enrichment is cumbersome. Therefore, the plasma C5 glucose–to–2H2O rather than the plasma C5-to-C2 glucose ratio commonly has been used to measure gluconeogenesis and glycogenolysis during hyperinsulinemic-euglycemic clamps. The validity of this approach is unknown.

RESEARCH DESIGN AND METHODS—Ten nondiabetic and 10 diabetic subjects ingested 2H2O the evening before study. The following morning, insulin was infused at a rate of 0.6 mU · kg–1 · min–1 and glucose was clamped at ~5.3 mmol/l for 5 h. Plasma C5 glucose, C2 glucose, and 2H2O enrichments were measured hourly from 2 h onward.

RESULTS—Plasma C2 glucose and plasma 2H2O enrichment were equal in both groups before the clamp, resulting in equivalent estimates of gluconeogenesis and glycogenolysis. In contrast, plasma C2 glucose and plasma C5 glucose enrichments fell throughout the clamp, whereas plasma 2H2O enrichment remained unchanged. Since the C5 glucose concentration and, hence, the C5 glucose–to–2H2O ratio is influenced by both gluconeogenesis and glucose clearance, whereas the C5-to-C2 glucose ratio is only influenced by gluconeogenesis, the C5 glucose–to–2H2O ratio overestimated (P < 0.01) gluconeogenesis during the clamp. This resulted in biologically implausible negative (i.e., calculated rates of gluconeogenesis exceeding total endogenous glucose production) rates of glycogenolysis in both the nondiabetic and diabetic subjects.

CONCLUSIONS—Plasma C5 glucose–to–2H2O ratio does not provide an accurate assessment of gluconeogenesis in nondiabetic or diabetic subjects during a traditional (i.e., 2–3 h) hyperinsulinemic-euglycemic clamp. The conclusions of studies that have used this approach need to be reevaluated.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.